Rimantas Slibinskas

Dr. Rimantas Slibinskas

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Maryia DrobyshMaryia Drobysh
Maryia Drobysh
VLViktorija Liustrovaite
Viktorija Liustrovaite
ABAusra Baradoke
Ausra Baradoke
ARAlma Rucinskiene
Alma Rucinskiene
Almira RamanavicieneAlmira Ramanaviciene
Almira Ramanaviciene
Arũnas RamanavičiusArũnas Ramanavičius
Arũnas Ramanavičius
The serologic diagnosis of coronavirus disease 2019 (COVID-19) and the evaluation of vaccination effectiveness are identified by the presence of antibodies specific to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this paper, we present the electrochemical-based biosensing technique for the detection of antibodies specific to the SARS-CoV-2 proteins. Recombinant SARS-CoV-2 spike proteins (rSpike) were immobilised on the surface of a gold electrode modified by a self-assembled monolayer (SAM). This modified electrode was used as a sensitive element for the detection of polyclonal mouse antibodies against the rSpike (anti-rSpike). Electrochemical impedance spectroscopy (EIS) was used to observe the formation of immunocomplexes while cyclic voltammetry (CV) was used for additional analysis of the surface modifications. It was revealed that the impedimetric method and the elaborate experimental conditions are appropriate for the further development of electrochemical biosensors for the serological diagnosis of COVID-19 and/or the confirmation of successful vaccination against SARS-CoV-2.

Verified
Journal Article
Open access
PDF file
FMFarah Perveen Mughal
Farah Perveen Mughal
ABAnn Christina Bergmann
Ann Christina Bergmann
HHHa Uyen Buu Huynh
Ha Uyen Buu Huynh
SJSarah Hyllekvist Jørgensen
Sarah Hyllekvist Jørgensen
IMInaam Mansha
Inaam Mansha
NTNicole Hartwig Trier
Nicole Hartwig Trier
Myeloproliferative Neoplasms (MPNs) constitute a group of rare blood cancers that are characterized by mutations in bone marrow stem cells leading to the overproduction of erythrocytes, leukocytes, and thrombocytes. Mutations in calreticulin (CRT) genes may initiate MPNs, causing a novel variable polybasic stretch terminating in a common C-terminal sequence in the frameshifted CRT (CRTfs) proteins. Peptide antibodies to the mutated C-terminal are important reagents for research in the molecular mechanisms of MPNs and for the development of new diagnostic assays and therapies. In this study, eight peptide antibodies targeting the C-terminal of CRTfs were produced and characterised by modified enzyme-linked immunosorbent assays using resin-bound peptides. The antibodies reacted to two epitopes: CREACLQGWTE for SSI-HYB 385-01, 385-02, 385-03, 385-04, 385-07, 385-08, and 385-09 and CLQGWT for SSI-HYB 385-06. For the majority of antibodies, the residues Cys1, Trp9, and Glu11 were essential for reactivity. SSI-HYB 385-06, with the highest affinity, recognised recombinant CRTfs produced in yeast and the MARIMO cell line expressing CRTfs when examined in Western immunoblotting. Moreover, SSI-HYB 385-06 occasionally reacted to CRTfs from MPN patients when analysed by flow cytometry. The characterized antibodies may be used to understand the role of CRTfs in the pathogenesis of MPNs and to design and develop new diagnostic assays and therapeutic targets.

1 January 2013 in Proteome Science
Verified
Journal Article
Open access
PDF file
RSRimantas Slibinskas
Rimantas Slibinskas
RRRaimundas Ražanskas
Raimundas Ražanskas
Rūta ZinkevičiūtėRūta Zinkevičiūtė
Rūta Zinkevičiūtė
EČEvaldas Čiplys
Evaldas Čiplys
Two-dimensional gel electrophoresis (2DE) is one of the most popular methods in proteomics. Currently, most 2DE experiments are performed using immobilized pH gradient (IPG) in the first dimension; however, some laboratories still use carrier ampholytes-based isoelectric focusing technique. The aim of this study was to directly compare IPG-based and non-equilibrium pH gradient electrophoresis (NEPHGE)-based 2DE techniques by using the same samples and identical second dimension procedures. We have used commercially available Invitrogen ZOOM IPGRunner and WITAvision systems for IPG and NEPHGE, respectively. The effectiveness of IPG-based and NEPHGE-based 2DE methods was compared by analysing differential protein expression during cytosolic unfolded protein response (UPR-Cyto) in Saccharomyces cerevisiae.

12 October 2023 in Talanta
Verified
Journal Article
Closed access
ABAusra Baradoke
Ausra Baradoke
AJAinis Jarusaitis
Ainis Jarusaitis
VRViktorija Reinikovaite
Viktorija Reinikovaite
AJAli Jafarov
Ali Jafarov
AEAlexandra Elsakova
Alexandra Elsakova
Arũnas RamanavičiusArũnas Ramanavičius
Arũnas Ramanavičius

4 August 2021 in Antibodies
Verified
Journal Article
Open access
PDF file
ABAnn Christina Bergmann
Ann Christina Bergmann
CKCecilie Kyllesbech
Cecilie Kyllesbech
RSRimantas Slibinskas
Rimantas Slibinskas
ECEvaldas Ciplys
Evaldas Ciplys
PHPeter Hojrup
Peter Hojrup
GHGunnar Houen
Gunnar Houen
Calreticulin is a chaperone protein, which is associated with myeloproliferative diseases. In this study, we used resin-bound peptides to characterize two monoclonal antibodies (mAbs) directed to calreticulin, mAb FMC 75 and mAb 16, which both have significantly contributed to understanding the biological function of calreticulin. The antigenicity of the resin-bound peptides was determined by modified enzyme-linked immunosorbent assay. Specific binding was determined to an 8-mer epitope located in the N-terminal (amino acids 34–41) and to a 12-mer peptide located in the C-terminal (amino acids 362–373). Using truncated peptides, the epitopes were identified as TSRWIESK and DEEQRLKEEED for mAb FMC 75 and mAb 16, respectively, where, especially the charged amino acids, were found to have a central role for a stable binding. Further studies indicated that the epitope of mAb FMC 75 is assessable in the oligomeric structure of calreticulin, making this epitope a potential therapeutic target.

Verified
Journal Article
Open access
PDF file
NTNicole Hartwig Trier
Nicole Hartwig Trier
NVNiccolo Valdarnini
Niccolo Valdarnini
IFIlaria Fanelli
Ilaria Fanelli
PRPaolo Rovero
Paolo Rovero
PHPaul Robert Hansen
Paul Robert Hansen
GHGunnar Houen
Gunnar Houen
Two isoforms of the glutamate decarboxylase (GAD) enzyme exist, GAD65 and GAD67, which are associated with type 1 diabetes (T1D) and stiff-person syndrome (SPS), respectively. Interestingly, it has been reported that T1D patients seldom develop SPS, whereas patients with SPS occasionally develop T1D. In addition, coxsackievirus B4 (CVB4) has previously been proposed to be involved in the onset of T1D through molecular mimicry. On this basis, we aimed to examine antibody cross-reactivity between a specific region of GAD65 and GAD67, which has high sequence homology to the nonstructural P2C protein of CVB4 to determine potential correlations at antibody level. Monoclonal peptide antibodies generated in mice specific for a region with high similarity in all three proteins were screened for reactivity along with human sera in immunoassays. In total, six antibodies were generated. Two of the antibodies reacted to both GAD isoforms. However, none of the antibodies were cross-reactive to CVB, suggesting that antibody cross-reactivity between GAD65 and CVB, and GAD67 and CVB may not contribute to the onset of T1D and SPS, respectively.